News from Thursday, February 5, 2026
Articles
Medical Care Supplement Highlights the Capacity of PCORnet® to Power Patient-Centered Research
(2/5, PCORnet Blog) comments “...Titled, ‘Accelerating Patient-Centered Comparative Clinical Effectiveness Research: A Special Article Collection in Medical Care,’ the supplement offers an in-depth look at how the PCORnet infrastructure supports patient-centered health research, drives innovation, and enables high-impact research at a national scale. The supplement features 19 peer-reviewed, open-access articles that highlight the strong scientific value of PCORnet in advancing patient-centered health research. Together, the articles introduce the PCORnet infrastructure, trace the network’s growth over the past decade, showcase inspiring examples of research powered by PCORnet®, explore innovative approaches to engagement and partnership, and share insights from PCORnet® Network Partners on implementing new technologies.” Full
Next Up for Congress: Pharma Execs.
(2/4, Megan R. Wilson, The Washington Post) reports “...The House is turning its attention to the pharmaceutical industry as it tackles the issue of health care affordability in an election year - calling executives to testify about the ‘root’ causes of drug prices next Wednesday. It follows a hearing last month where lawmakers grilled the CEOs of the nation's top health insurance companies.” Subscription Required
Journals
Nivolumab plus Ipilimumab Versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
Jiefeng Luo PhD, et al.
February 1, 2026, Cancer
Lower Extremity Complications in Adults with Type 2 Diabetes Treated with GLP-1 Receptor Agonists, SGLT2 Inhibitors, DPP4 Inhibitors, and Sulfonylureas: An Emulated Target Trial
Rozalina G McCoy, et al.
February 2, 2026, Endocrine Practice
Comparative Effectiveness of Biologics in Lung Function Improvement among Patients with Severe Asthma: A Real-World Study
Arnaud Bourdin, et al.
February 4, 2026, Respiratory Research
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder
Joao Vitor Mahler, et al.
March 2026, Neurology, Neuroimmunology & Neuroinflammation